PubHawk
JCO Precis Oncol December 2022 PMID 36480779

Analysis of Circulating Tumor DNA to Predict Risk of Recurrence in Patients With Esophageal and Gastric Cancers.

Brandon M Huffman, Vasily N Aushev, Griffin L Budde, Joseph Chao, Farshid Dayyani, Diana Hanna, Gregory P Botta, Daniel V T Catenacci, Steven B Maron, Shifra Krinshpun, Shruti Sharma, Giby V George, Meenakshi Malhotra, Adham Jurdi, Solomon Moshkevich

Full text PDF Download social card

Mentions

159
Peak: 105 in Dec 2022
across 3 sources since Dec 2022

Extended reach

540,765
potential audience

Total likes

285

Video views

23

Mentions per month

Dec 2022 – Apr 2024

Where it's discussed

  • X / Twitter106 posts
  • News52 articles
  • YouTube1 videos

AI synopsis

What people are saying

Discussions highlight the publication's significance, with phrases like 'highly prognostic' and 'exceptional response' indicating enthusiasm about potential advancements in patient management. Contributors emphasize the feasibility of ctDNA detection in post-surgical settings, noting that it can enhance risk stratification during curative therapy, which suggests a proactive approach to cancer treatment using modern technology.

AgreementModerate agreement

Most discussions reflect a positive reception to the findings, indicating a shared understanding of their significance.

InterestHigh interest

Many posts express strong curiosity about the implications of ctDNA analysis, showing relevance to ongoing research and patient care.

EngagementModerate engagement

Some contributors delve into specific patient cases, demonstrating a deeper analysis of the publication's methodology and results.

ImpactHigh impact

There is a strong consensus that the publication has substantial potential to influence treatment approaches in esophageal and gastric cancers.

Abstract in brief

  • Circulating tumor DNA (ctDNA) analyses show promise for risk assessment in esophagogastric cancers (EGC), similar to its established use in colon and breast cancers.
  • A study analyzed ctDNA levels in 295 EGC patients pre- and post-surgery, finding high detection rates that correlated with disease recurrence.
  • Results indicated that ctDNA detection at various points post-surgery significantly predicted shorter recurrence-free survival, highlighting its potential role in patient management after curative treatment.
Read the full abstract

Top posts

Most liked on X and Bluesky
Sam Klempner
@KlempnerSam · X

Fellow led project from @BHuffmanMD who is now faculty @DanaFarber @ASCO @JCOPO_ASCO Analysis of ctDNA to Predict Risk of Recurrence in Patients With Esophageal and Gastric Cancers https://t.co/aQ5q02t2zl

Dec 8, 2022 · 47 likes · 15 shares · 4,694 followers View post →
Pashtoon Kasi MD, MS
@pashtoonkasi · X

Dec 8, 2022 · 44 likes · 18 shares · 19,738 followers View post →
Brandon Huffman, MD
@BHuffmanMD · X

Happy to share our publication on tumor-informed circulating tumor DNA in patients with gastric, GEJ, and esophageal cancers. See our @JCOPO_ASCO manuscript out today: https://t.co/63RnOisFeZ #ctDNA

Dec 8, 2022 · 43 likes · 18 shares · 1,084 followers View post →
Pashtoon Kasi MD, MS
@pashtoonkasi · X

Sounds like we were popular @JCOPO_ASCO @ASCO

Dec 17, 2022 · 42 likes · 17 shares · 19,738 followers View post →
Arndt Vogel
@ArndtVogel · X

Dec 14, 2022 · 36 likes · 13 shares · 8,778 followers View post →
ilyas sahin, MD
@ilyassahinMD · X

T:

Dec 15, 2022 · 26 likes · 20,854 followers View post →

All mentions

Lauren
@elrenres · X

RT @BHuffmanMD: Happy to share our publication on tumor-informed circulating tumor DNA in patients with gastric, GEJ, and esophageal cancer…

Feb 2, 2023 · 18 shares · 121 followers View post →
Rahul Pathak
@SumitPathak261 · X

RT @JCOPO_ASCO:

Dec 22, 2022 · 10 shares · 1,008 followers View post →
OGCancerNI
@OGCancerNI · X

RT @JCOPO_ASCO:

Dec 19, 2022 · 10 shares · 705 followers View post →
ASCO
@ASCO · X

RT @JCOPO_ASCO:

Dec 19, 2022 · 10 shares · 149,567 followers View post →
raerae
@raely_31 · X

RT @pashtoonkasi: Sounds like we were popular @JCOPO_ASCO @ASCO

Dec 18, 2022 · 17 shares · 2 followers View post →
Zach Yeung MD
@zpyeung · X

RT @pashtoonkasi: Sounds like we were popular @JCOPO_ASCO @ASCO

Dec 18, 2022 · 17 shares · 671 followers View post →
Adzabe Nana-Yao MD
@adzabe_ny · X

RT @pashtoonkasi: Sounds like we were popular @JCOPO_ASCO @ASCO

Dec 18, 2022 · 17 shares · 14 followers View post →
Dr Shantanu SG Kulkarni
@CancerYoddha · X

RT @JCOPO_ASCO:

Dec 17, 2022 · 10 shares · 633 followers View post →
Eric Thompson, Ph.D.
@AZBioMarkers · X

RT @pashtoonkasi: Building on our @JCOPO_ASCO publication, I have this patient with stage-IV HER2➕➕➕gastric cancer with an exceptional resp…

Dec 17, 2022 · 2 shares · 409 followers View post →
Sewanti Limaye
@SewantiLimaye · X

RT @pashtoonkasi: Sounds like we were popular @JCOPO_ASCO @ASCO

Dec 17, 2022 · 17 shares · 3,105 followers View post →
Arto Kokkola
@ArtoKokkola · X

RT @pashtoonkasi: Sounds like we were popular @JCOPO_ASCO @ASCO

Dec 17, 2022 · 17 shares · 32 followers View post →
Santhosh Ambika
@RenoHemonc · X

RT @pashtoonkasi: Sounds like we were popular @JCOPO_ASCO @ASCO

Dec 17, 2022 · 17 shares · 4,050 followers View post →
OncoAlert
@OncoAlert · X

RT @pashtoonkasi: Sounds like we were popular @JCOPO_ASCO @ASCO

Dec 17, 2022 · 17 shares · 40,156 followers View post →
Pashtoon Kasi MD, MS
@pashtoonkasi · X

Building on our @JCOPO_ASCO publication, I have this patient with stage-IV HER2➕➕➕gastric cancer with an exceptional response who made it to surgery. However, never turned #ctDNA➖. High risk path. Gave T-DXd “2nd” line➡️➖right away & on a holiday.

Dec 17, 2022 · 17 likes · 2 shares · 19,738 followers View post →
Tevfik Ergül
@tergul06 · X

RT @pashtoonkasi: Sounds like we were popular @JCOPO_ASCO @ASCO

Dec 17, 2022 · 17 shares · 774 followers View post →
Ricardo Carvalho
@rcarvalhoonco · X

RT @pashtoonkasi: Sounds like we were popular @JCOPO_ASCO @ASCO

Dec 17, 2022 · 17 shares · 2,265 followers View post →
Katsuaki Maehara
@KatsuakiMaehara · X

RT @pashtoonkasi: Sounds like we were popular @JCOPO_ASCO @ASCO

Dec 17, 2022 · 17 shares · 2,981 followers View post →
Masoom Kasi
@masoomkassi · X

RT @pashtoonkasi: Sounds like we were popular @JCOPO_ASCO @ASCO

Dec 17, 2022 · 17 shares · 119 followers View post →
Marco A
@aurelioassad · X

RT @pashtoonkasi: Sounds like we were popular @JCOPO_ASCO @ASCO

Dec 17, 2022 · 17 shares · 155 followers View post →
Michael R Freund MD
@mikifreund · X

RT @pashtoonkasi: Sounds like we were popular @JCOPO_ASCO @ASCO

Dec 17, 2022 · 17 shares · 362 followers View post →
Arun Nagarajan
@ArunNagarajanMD · X

RT @pashtoonkasi: Sounds like we were popular @JCOPO_ASCO @ASCO

Dec 17, 2022 · 17 shares · 528 followers View post →
Umberto Malapelle
@UmbertoMalapel1 · X

RT @pashtoonkasi: Sounds like we were popular @JCOPO_ASCO @ASCO

Dec 17, 2022 · 17 shares · 3,381 followers View post →
Gavin Strachan
@CCGav · X

RT @pashtoonkasi: Sounds like we were popular @JCOPO_ASCO @ASCO

Dec 17, 2022 · 17 shares · 258 followers View post →
Pashtoon Kasi MD, MS
@pashtoonkasi · X

Sounds like we were popular @JCOPO_ASCO @ASCO

Dec 17, 2022 · 42 likes · 17 shares · 19,738 followers View post →
Pashtoon Kasi MD, MS
@pashtoonkasi · X

RT @JCOPO_ASCO:

Dec 16, 2022 · 10 shares · 19,738 followers View post →
Daniel Catenacci
@DocCatenacci · X

RT @JCOPO_ASCO:

Dec 16, 2022 · 10 shares · 2,894 followers View post →
Adham Jurdi
@OncoJurdi · X

RT @JCOPO_ASCO:

Dec 16, 2022 · 10 shares · 1,116 followers View post →
Sam Klempner
@KlempnerSam · X

RT @JCOPO_ASCO:

Dec 16, 2022 · 10 shares · 4,694 followers View post →
Brandon Huffman, MD
@BHuffmanMD · X

RT @JCOPO_ASCO:

Dec 16, 2022 · 10 shares · 1,084 followers View post →
JCO Precision Oncology
@JCOPO_ASCO · X

Dec 16, 2022 · 21 likes · 10 shares · 5,311 followers View post →
Mónica Meneses
@MoniquMeneses · X

RT @ArndtVogel:

Dec 15, 2022 · 13 shares · 671 followers View post →
Ali Erdem
@life_walker · X

RT @ArndtVogel:

Dec 15, 2022 · 13 shares · 223 followers View post →
Nelly, Chien-Jui Huang
@nellyhuang91 · X

RT @ArndtVogel:

Dec 15, 2022 · 13 shares · 230 followers View post →
DARIO SERAFINO
@DarioWSeraf · X

RT @ArndtVogel:

Dec 15, 2022 · 13 shares · 90 followers View post →
Suneel Kamath MD
@SKamath_MD · X

RT @ArndtVogel:

Dec 15, 2022 · 13 shares · 2,666 followers View post →
Sukeshi Arora MD
@DrSukeshiArora · X

RT @ArndtVogel:

Dec 15, 2022 · 13 shares · 956 followers View post →
Dr Zachary Veitch
@z_veitch · X

RT @ArndtVogel:

Dec 15, 2022 · 13 shares · 575 followers View post →
ilyas sahin, MD
@ilyassahinMD · X

T:

Dec 15, 2022 · 26 likes · 20,854 followers View post →
Gregory Botta
@gregorybotta · X

RT @BHuffmanMD: Happy to share our publication on tumor-informed circulating tumor DNA in patients with gastric, GEJ, and esophageal cancer…

Dec 15, 2022 · 18 shares · 102 followers View post →
Emma B. Holliday MD
@DrEmmaHolliday · X

RT @ArndtVogel:

Dec 15, 2022 · 13 shares · 9,464 followers View post →
Garrett Green, MD
@ggreen1986 · X

RT @ArndtVogel:

Dec 15, 2022 · 13 shares · 868 followers View post →
OncoAlert
@OncoAlert · X

RT @ArndtVogel:

Dec 15, 2022 · 13 shares · 40,156 followers View post →
Asaf Maoz
@asaf_maoz · X

RT @BHuffmanMD: Happy to share our publication on tumor-informed circulating tumor DNA in patients with gastric, GEJ, and esophageal cancer…

Dec 14, 2022 · 18 shares · 1,398 followers View post →
JCO Precision Oncology
@JCOPO_ASCO · X

RT @ArndtVogel:

Dec 14, 2022 · 13 shares · 5,311 followers View post →
Wolfgang Kunz
@WolfgangGKunzMD · X

RT @ArndtVogel:

Dec 14, 2022 · 13 shares · 547 followers View post →
Alan Burguete-Torres M.D.
@dralanburguete · X

RT @ArndtVogel:

Dec 14, 2022 · 13 shares · 1,536 followers View post →
Arndt Vogel
@ArndtVogel · X

Dec 14, 2022 · 36 likes · 13 shares · 8,778 followers View post →
@investigando
@rocatanho · X

Detección de DNA tumoral circulante en el postoperatorio del cáncer esofagogástrico es factible y permite mejorar la estratificación y pronóstico del riesgo del paciente durante la terapia con intención curativa #ctDNA #risk #cancer https://t.co/Q0sIio1z8g

Dec 14, 2022 · 400 followers View post →
Jonathan Loree
@jonathanloree · X

RT @KlempnerSam: Fellow led project from @BHuffmanMD who is now faculty @DanaFarber @ASCO @JCOPO_ASCO Analysis of ctDNA to Predict Risk…

Dec 14, 2022 · 15 shares · 824 followers View post →
Brandon Huffman, MD
@BHuffmanMD · X

RT @pashtoonkasi:

Dec 14, 2022 · 18 shares · 1,084 followers View post →
Pashtoon Kasi MD, MS
@pashtoonkasi · X

RT @KlempnerSam: Fellow led project from @BHuffmanMD who is now faculty @DanaFarber @ASCO @JCOPO_ASCO Analysis of ctDNA to Predict Risk…

Dec 14, 2022 · 15 shares · 19,738 followers View post →
Pashtoon Kasi MD, MS
@pashtoonkasi · X

RT @BHuffmanMD: Happy to share our publication on tumor-informed circulating tumor DNA in patients with gastric, GEJ, and esophageal cancer…

Dec 14, 2022 · 18 shares · 19,738 followers View post →
cfDNA papers
@cfDNA_papers · X

Analysis of Circulating Tumor DNA to Predict Risk of Recurrence in Patients With Esophageal and Gastric Cancers https://t.co/EEJZER0Hq5 https://t.co/XYXs93GQSC

Dec 12, 2022 · 1 like · 621 followers View post →
Ryan Palusak
@Palusak · X

RT @pashtoonkasi:

Dec 12, 2022 · 18 shares · 71 followers View post →
TerriConneran
@TerriConneran · X

RT @BHuffmanMD: Happy to share our publication on tumor-informed circulating tumor DNA in patients with gastric, GEJ, and esophageal cancer…

Dec 11, 2022 · 18 shares · 1,164 followers View post →
Alexandra Gangi, MD
@AGangiMD · X

RT @BHuffmanMD: Happy to share our publication on tumor-informed circulating tumor DNA in patients with gastric, GEJ, and esophageal cancer…

Dec 11, 2022 · 18 shares · 2,829 followers View post →
R8Plus
@AAABiotech · X

RT @pashtoonkasi:

Dec 11, 2022 · 18 shares · 1,236 followers View post →
BE.Johnson.MD
@bejmedonc · X

RT @pashtoonkasi:

Dec 11, 2022 · 18 shares · 275 followers View post →
Ahmed Tayel
@AhmedTayel13 · X

RT @pashtoonkasi:

Dec 11, 2022 · 18 shares · 361 followers View post →
Brandon Huffman, MD
@BHuffmanMD · X

RT @BHuffmanMD: Happy to share our publication on tumor-informed circulating tumor DNA in patients with gastric, GEJ, and esophageal cancer…

Dec 11, 2022 · 18 shares · 1,084 followers View post →
Dr Zachary Veitch
@z_veitch · X

RT @pashtoonkasi:

Dec 11, 2022 · 18 shares · 575 followers View post →
Pashtoon Kasi MD, MS
@pashtoonkasi · X

RT @pashtoonkasi:

Dec 11, 2022 · 18 shares · 19,738 followers View post →
Gregory Botta
@gregorybotta · X

RT @pashtoonkasi:

Dec 9, 2022 · 18 shares · 102 followers View post →
Gregory Botta
@gregorybotta · X

https://t.co/VXVA6YhTqc

Dec 9, 2022 · 102 followers View post →
Suneel Kamath MD
@SKamath_MD · X

RT @pashtoonkasi:

Dec 9, 2022 · 18 shares · 2,666 followers View post →
JCO Precision Oncology
@JCOPO_ASCO · X

RT @BHuffmanMD: Happy to share our publication on tumor-informed circulating tumor DNA in patients with gastric, GEJ, and esophageal cancer…

Dec 9, 2022 · 18 shares · 5,311 followers View post →
Griffin Budde, PharmD
@GBudde_SkinMRD · X

RT @BHuffmanMD: Happy to share our publication on tumor-informed circulating tumor DNA in patients with gastric, GEJ, and esophageal cancer…

Dec 9, 2022 · 18 shares · 161 followers View post →
Griffin Budde, PharmD
@GBudde_SkinMRD · X

RT @pashtoonkasi:

Dec 9, 2022 · 18 shares · 161 followers View post →
Griffin Budde, PharmD
@GBudde_SkinMRD · X

RT @OncoJurdi: Hot off the press! @JCOPO_ASCO In a multicenter RWE collaboration, Signatera #ctDNA assay is highly prognostic in Esophagea…

Dec 9, 2022 · 3 shares · 161 followers View post →
Griffin Budde, PharmD
@GBudde_SkinMRD · X

RT @KlempnerSam: Fellow led project from @BHuffmanMD who is now faculty @DanaFarber @ASCO @JCOPO_ASCO Analysis of ctDNA to Predict Risk…

Dec 9, 2022 · 15 shares · 161 followers View post →
Guglielmo Vetere, MD
@Guv_onc · X

RT @pashtoonkasi:

Dec 9, 2022 · 18 shares · 126 followers View post →
爱母Q
@Q34566201 · X

RT @pashtoonkasi:

Dec 9, 2022 · 18 shares · 39 followers View post →
Rafeh Naqash, MD, FASCO
@thenasheffect · X

RT @OncoJurdi: Hot off the press! @JCOPO_ASCO In a multicenter RWE collaboration, Signatera #ctDNA assay is highly prognostic in Esophagea…

Dec 9, 2022 · 3 shares · 2,614 followers View post →
Efrat Dotan MD
@efratdotan · X

RT @KlempnerSam: Fellow led project from @BHuffmanMD who is now faculty @DanaFarber @ASCO @JCOPO_ASCO Analysis of ctDNA to Predict Risk…

Dec 9, 2022 · 15 shares · 683 followers View post →
Asaf Maoz
@asaf_maoz · X

RT @KlempnerSam: Fellow led project from @BHuffmanMD who is now faculty @DanaFarber @ASCO @JCOPO_ASCO Analysis of ctDNA to Predict Risk…

Dec 9, 2022 · 15 shares · 1,398 followers View post →
Christopher G. Smith
@Chris_G_Smith1 · X

RT @pashtoonkasi:

Dec 9, 2022 · 18 shares · 406 followers View post →
Ricardo Carvalho
@rcarvalhoonco · X

RT @KlempnerSam: Fellow led project from @BHuffmanMD who is now faculty @DanaFarber @ASCO @JCOPO_ASCO Analysis of ctDNA to Predict Risk…

Dec 9, 2022 · 15 shares · 2,265 followers View post →
Pamela Almeida
@pam65230529 · X

RT @BHuffmanMD: Happy to share our publication on tumor-informed circulating tumor DNA in patients with gastric, GEJ, and esophageal cancer…

Dec 9, 2022 · 18 shares · 217 followers View post →
Patxi Queipo
@patxiqueipo · X

RT @pashtoonkasi:

Dec 9, 2022 · 18 shares · 447 followers View post →
Jp Solar Vasconcelos
@jaypsv · X

RT @BHuffmanMD: Happy to share our publication on tumor-informed circulating tumor DNA in patients with gastric, GEJ, and esophageal cancer…

Dec 9, 2022 · 18 shares · 674 followers View post →
Ali Erdem
@life_walker · X

RT @pashtoonkasi:

Dec 9, 2022 · 18 shares · 223 followers View post →
Ali Erdem
@life_walker · X

RT @BHuffmanMD: Happy to share our publication on tumor-informed circulating tumor DNA in patients with gastric, GEJ, and esophageal cancer…

Dec 9, 2022 · 18 shares · 223 followers View post →
Jun Gong
@jgong15 · X

RT @KlempnerSam: Fellow led project from @BHuffmanMD who is now faculty @DanaFarber @ASCO @JCOPO_ASCO Analysis of ctDNA to Predict Risk…

Dec 9, 2022 · 15 shares · 1,663 followers View post →
Masoom Kasi
@masoomkassi · X

RT @pashtoonkasi:

Dec 9, 2022 · 18 shares · 119 followers View post →
filippo masini
@filimasini · X

RT @KlempnerSam: Fellow led project from @BHuffmanMD who is now faculty @DanaFarber @ASCO @JCOPO_ASCO Analysis of ctDNA to Predict Risk…

Dec 9, 2022 · 15 shares · 770 followers View post →
Elad Sharon
@EladSharonMD · X

RT @KlempnerSam: Fellow led project from @BHuffmanMD who is now faculty @DanaFarber @ASCO @JCOPO_ASCO Analysis of ctDNA to Predict Risk…

Dec 9, 2022 · 15 shares · 3,869 followers View post →
Davide Ciardiello
@DCiardiello · X

RT @KlempnerSam: Fellow led project from @BHuffmanMD who is now faculty @DanaFarber @ASCO @JCOPO_ASCO Analysis of ctDNA to Predict Risk…

Dec 9, 2022 · 15 shares · 475 followers View post →
Benjamin Weinberg, MD, FACP
@benweinbergmd · X

RT @KlempnerSam: Fellow led project from @BHuffmanMD who is now faculty @DanaFarber @ASCO @JCOPO_ASCO Analysis of ctDNA to Predict Risk…

Dec 8, 2022 · 15 shares · 2,815 followers View post →
Alan Burguete-Torres M.D.
@dralanburguete · X

RT @BHuffmanMD: Happy to share our publication on tumor-informed circulating tumor DNA in patients with gastric, GEJ, and esophageal cancer…

Dec 8, 2022 · 18 shares · 1,536 followers View post →
Elad Sharon
@EladSharonMD · X

RT @BHuffmanMD: Happy to share our publication on tumor-informed circulating tumor DNA in patients with gastric, GEJ, and esophageal cancer…

Dec 8, 2022 · 18 shares · 3,869 followers View post →
Ricardo Silva
@silvamricardo · X

RT @BHuffmanMD: Happy to share our publication on tumor-informed circulating tumor DNA in patients with gastric, GEJ, and esophageal cancer…

Dec 8, 2022 · 18 shares · 121 followers View post →
Ricardo Silva
@silvamricardo · X

RT @KlempnerSam: Fellow led project from @BHuffmanMD who is now faculty @DanaFarber @ASCO @JCOPO_ASCO Analysis of ctDNA to Predict Risk…

Dec 8, 2022 · 15 shares · 121 followers View post →
ctSEQpapers
@ctSEQ_papers · X

PubMed_ Analysis of Circulating Tumor DNA to Predict Risk of Recurrence in Patients With Esophageal and Gastric Cancers https://t.co/h2zQOGzZj9

Dec 8, 2022 · 161 followers View post →
Anwaar Saeed
@AnwaarSaeed3 · X

RT @pashtoonkasi:

Dec 8, 2022 · 18 shares · 3,111 followers View post →
Adham Jurdi
@OncoJurdi · X

RT @BHuffmanMD: Happy to share our publication on tumor-informed circulating tumor DNA in patients with gastric, GEJ, and esophageal cancer…

Dec 8, 2022 · 18 shares · 1,116 followers View post →
Alejandro Rosales
@HpbNicaragua · X

RT @BHuffmanMD: Happy to share our publication on tumor-informed circulating tumor DNA in patients with gastric, GEJ, and esophageal cancer…

Dec 8, 2022 · 18 shares · 1,335 followers View post →
JCO Precision Oncology
@JCOPO_ASCO · X

RT @OncoJurdi: Hot off the press! @JCOPO_ASCO In a multicenter RWE collaboration, Signatera #ctDNA assay is highly prognostic in Esophagea…

Dec 8, 2022 · 3 shares · 5,311 followers View post →
JCO Precision Oncology
@JCOPO_ASCO · X

RT @KlempnerSam: Fellow led project from @BHuffmanMD who is now faculty @DanaFarber @ASCO @JCOPO_ASCO Analysis of ctDNA to Predict Risk…

Dec 8, 2022 · 15 shares · 5,311 followers View post →
JCO Precision Oncology
@JCOPO_ASCO · X

RT @pashtoonkasi:

Dec 8, 2022 · 18 shares · 5,311 followers View post →
Pashtoon Kasi MD, MS
@pashtoonkasi · X

Dec 8, 2022 · 44 likes · 18 shares · 19,738 followers View post →
Adham Jurdi
@OncoJurdi · X

Hot off the press! @JCOPO_ASCO In a multicenter RWE collaboration, Signatera #ctDNA assay is highly prognostic in Esophageal and Gastric cancers. HR=10.7 in postsurgical window and 17.7 during surveillance. https://t.co/9WPwv0Hu3C https://t.co/acdR5nP5Gp

Dec 8, 2022 · 7 likes · 3 shares · 1,116 followers View post →
Brandon Huffman, MD
@BHuffmanMD · X

RT @KlempnerSam: Fellow led project from @BHuffmanMD who is now faculty @DanaFarber @ASCO @JCOPO_ASCO Analysis of ctDNA to Predict Risk…

Dec 8, 2022 · 15 shares · 1,084 followers View post →
Geoff Oxnard MD
@geoff_oxnard · X

RT @KlempnerSam: Fellow led project from @BHuffmanMD who is now faculty @DanaFarber @ASCO @JCOPO_ASCO Analysis of ctDNA to Predict Risk…

Dec 8, 2022 · 15 shares · 4,001 followers View post →
Michael LaPelusa, MD
@MichaelLaPelusa · X

RT @BHuffmanMD: Happy to share our publication on tumor-informed circulating tumor DNA in patients with gastric, GEJ, and esophageal cancer…

Dec 8, 2022 · 18 shares · 1,078 followers View post →
Brandon Huffman, MD
@BHuffmanMD · X

Happy to share our publication on tumor-informed circulating tumor DNA in patients with gastric, GEJ, and esophageal cancers. See our @JCOPO_ASCO manuscript out today: https://t.co/63RnOisFeZ #ctDNA

Dec 8, 2022 · 43 likes · 18 shares · 1,084 followers View post →
Sam Klempner
@KlempnerSam · X

Fellow led project from @BHuffmanMD who is now faculty @DanaFarber @ASCO @JCOPO_ASCO Analysis of ctDNA to Predict Risk of Recurrence in Patients With Esophageal and Gastric Cancers https://t.co/aQ5q02t2zl

Dec 8, 2022 · 47 likes · 15 shares · 4,694 followers View post →